User:    Password: 
2/12/2026

Moderna says FDA refuses its application for new mRNA flu vaccine
Associated Press
WASHINGTON (AP) — The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
 
FDA won’t review Moderna application for first mRNA-based flu vaccine
Washington Post
The Food and Drug Administration has declined to review Moderna’s application for the first mRNA-based flu vaccine, a decision that shocked the company and that comes as the agency plans to tighten federal vaccine approvals.
 

  
Vaccine innovation vs. the bureaucracy
Washington Post
Moderna spent years and hundreds of millions of dollars developing a flu vaccine using the same technology that allowed the United States to produce covid-19 vaccines in record time. But now the drug company’s flu shots are not getting a fair shake from the Food and Drug Administration.